EZH2-Inhibited MicroRNA-454-3p Promotes M2 Macrophage Polarization in Glioma
Authors:
Open Access
- 9 December 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 8
Abstract
Glioma is a primary intracranial tumor with high incidence and mortality. The oncogenic role of EZH2 has been reported in glioma. EZH2 inhibited microRNA-454-3p (miR-454-3p) by binding to its promoter in chondrosarcoma cells. Therefore, our study aimed to identify whether EZH2 regulated M2 macrophage polarization in glioma via miR-454-3p. Clinical samples of different grades of glioma and glioma cells were collected and immunohistochemistry and RT-qPCR demonstrated that EZH2 was highly expressed in glioma tissues. Expression of EZH2 was positively correlated with the degree of M2 macrophage polarization in glioma tissues. EZH2 was silenced by lentivirus in glioma cells, which were subsequently co-cultured with macrophages to evaluate its effect on macrophage polarization. miR-454-3p, a down-regulated miR in glioma, was found to be increased after silencing of EZH2. Furthermore, MethPrimer analysis showed that EZH2 silencing inhibited the DNA methylation level of miR-454-3p. Additionally, MS-PCR, dual-luciferase reporter, RIP and RNA pull down assays revealed that miR-454-3p promoted PTEN expression by inhibiting m6A modification through binding to the enzyme YTHDF2. Either inhibition of miR-454-3p or PTEN resulted in promotion of M2 macrophage polarization. Collectively, histone methyltransferase EZH2 inhibited miR-454-3p through methylation modification and promoted m6A modification of PTEN to induce glioma M2 macrophage polarization.Keywords
This publication has 39 references indexed in Scilit:
- YTHDF2 promotes mitotic entry and is regulated by cell cycle mediatorsPLOS Biology, 2020
- Transcriptional alterations in glioma result primarily from DNA methylation–independent mechanismsGenome Research, 2019
- MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of gliomaMolecular and Cellular Biochemistry, 2019
- m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomasAging, 2019
- Cognate Interaction With CD4+ T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like PhenotypeFrontiers in Immunology, 2019
- Retracted: MicroRNA‐21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathwayCNS Neuroscience & Therapeutics, 2018
- YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cellsCell Cycle, 2017
- Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growthCell Death & Disease, 2017
- Mechanistic and biological significance of DNA methyltransferase 1 upregulated by growth factors in human hepatocellular carcinomaInternational Journal of Oncology, 2014
- Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brainExpert Reviews in Molecular Medicine, 2011